| Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial T Cascone, CH Leung, A Weissferdt, A Pataer, BW Carter, MCB Godoy, ... Nature medicine 29 (3), 593-604, 2023 | 80 | 2023 |
| Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues S Hernandez, F Rojas, C Laberiano, R Lazcano, I Wistuba, ER Parra Frontiers in molecular biosciences 8, 667067, 2021 | 36 | 2021 |
| Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research R Frank, H Sharia, L Rossana, LF Caddie, P Edwin Roger Frontiers in Oncology 12, 2022 | 16 | 2022 |
| Best practices for technical reproducibility assessment of multiplex immunofluorescence C Laberiano-Fernández, S Hernández-Ruiz, F Rojas, ER Parra Frontiers in Molecular Biosciences 8, 660202, 2021 | 13 | 2021 |
| The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response ST Kundu, BL Rodriguez, LA Gibson, AN Warner, MG Perez, R Bajaj, ... Genes & Development 36 (9-10), 582-600, 2022 | 10 | 2022 |
| Pathomic features reveal immune and molecular evolution from lung preneoplasia to invasive adenocarcinoma P Chen, FR Rojas, X Hu, A Serrano, B Zhu, H Chen, L Hong, ... Modern Pathology 36 (12), 100326, 2023 | 8 | 2023 |
| Pathology quality control for multiplex immunofluorescence and image analysis assessment in longitudinal studies R Lazcano, F Rojas, C Laberiano, S Hernandez, ER Parra Frontiers in Molecular Biosciences 8, 661222, 2021 | 8 | 2021 |
| Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors LMS F Rojas, ER Parra, II Wistuba, C Haymaker Cancers 14 (11), 2775, 2022 | 7 | 2022 |
| Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance BL Rodriguez, L Chen, Y Li, S Miao, DH Peng, JJ Fradette, L Diao, ... Frontiers in immunology 14, 1161869, 2023 | 4 | 2023 |
| Cellular architecture on whole slide images allows the prediction of survival in lung adenocarcinoma P Chen, MB Saad, FR Rojas, M Salehjahromi, M Aminu, ... International Workshop on Computational Mathematics Modeling in Cancer …, 2022 | 4 | 2022 |
| Arteriolopatía cálcica urémica: comunicación de un caso y revisión de la literatura M Vassallo, I Bello, L Hamana, A Ferrer, F Rojas, H Cantele Revista Clínica Española 211 (7), e37-e41, 2011 | 3 | 2011 |
| Automated cellular-level dual global fusion of whole-slide imaging for lung adenocarcinoma prognosis S Diao, P Chen, E Showkatian, R Bandyopadhyay, FR Rojas, B Zhu, ... Cancers 15 (19), 4824, 2023 | 2 | 2023 |
| Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples L Campos Clemente, O Shi, F Rojas, ER Parra Journal of Visualized Experiments, e64015, 2022 | 1* | 2022 |
| Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial ER Parra, J Zhang, DY Duose, E Gonzalez-Kozlova, MW Redman, ... Clinical Cancer Research 30 (8), 1655-1668, 2024 | | 2024 |
| Spatial single-cell immune microenvironment analysis reveals the transition from innate to adaptive immune response during early lung adenocarcinoma carcinogenesis B Zhu, P Chen, M Aminu, J Fujimoto, L Hong, AL Moreira, JR Li, Y Tian, ... Cancer Research 84 (6_Supplement), 6098-6098, 2024 | | 2024 |
| Spatial analysis revealed distinct molecular and immune landscape in genetic versus carcinogen-induced lung adenocarcinoma precancer mouse models B Zhu, P Chen, JR Li, M Aminu, C Li, H Chen, Y Tian, FR Rojas, ... Cancer Research 84 (6_Supplement), 3387-3387, 2024 | | 2024 |
| Multi-omics analysis reveals immune features associated with immunotherapy benefit in squamous cell lung cancer patients from Phase III Lung-MAP S1400I trial. ER Parra, J Zhang, DY Duose, E Gonzalez-Kozlova, MW Redman, ... Clinical Cancer Research: an Official Journal of the American Association …, 2024 | | 2024 |
| Pathomics reveals the molecular and immune evolution from lung preneoplasia to invasive adenocarcinoma P Chen, F Rojas, X Hu, J Fujimoto, A Serrano, B Zhu, L Hong, ... Cancer Research 83 (7_Supplement), 5443-5443, 2023 | | 2023 |
| B-Cell Lymphoma R Bandyopadhyay¹, S El Hussein, FR Rojas, K Ebare¹, II Wistuba, ... Computational Mathematics Modeling in Cancer Analysis: First International …, 2022 | | 2022 |
| Is More Always Better? Effects of Patch Sampling in Distinguishing Chronic Lymphocytic Leukemia from Transformation to Diffuse Large B-Cell Lymphoma R Bandyopadhyay, P Chen, S El Hussein, FR Rojas, K Ebare, II Wistuba, ... International Workshop on Computational Mathematics Modeling in Cancer …, 2022 | | 2022 |
